Chemically, it is a Janus kinase (JAK) inhibitor. Baricitinib works by targeting and inhibiting specific enzymes involved in the inflammatory process, particularly JAK1 and JAK2. By modulating these pathways, it helps reduce inflammation and slow the progression of rheumatoid arthritis. Baricitinib is typically prescribed in combination with other disease-modifying antirheumatic drugs (DMARDs). Additionally, baricitinib has been investigated for its potential use in certain inflammatory conditions associated with COVID-19. Buy high quality Baricitinib from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Baricitinib